Formations Gestion Analyses CAC et StratÃ©gies de Trading

CNS: Fenetresurcours: NewsRenderer

Today is October 21, 2018. All times in Eastern Daylight Time.

Children’s Hospital Los Angeles ‘From Paris With Love’ Gala Raises $5.5 MILLION to Support Pediatric Medical Care and Research

10/21/2018 - 04:19 AM

LOS ANGELES--(BUSINESS WIRE)--In recognition for their compassion and dedicated support of Children’s Hospital Los Angeles (CHLA), late night talk show host and comedian Jimmy Kimmel, legendary Dod... more »
Takeda presenta los resultados del ensayo de fase 3 ALTA-1L que destaca la eficacia intracraneal de ALUNBRIG® (brigatinib) en comparación con crizotinib en el cáncer de pulmón amicrocítico ALK+ avanzado de primera línea

10/20/2018 - 09:20 PM

CAMBRIDGE, Massachusetts y OSAKA, Japón--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE: 4502) ha anunciado hoy que los datos de eficacia intracraneal del ensayo de fase 3 ALTA-1L (ALK... more »
Carson and Assa Abloy’s Mul-T-Lock Announce Partnership and Integration

10/20/2018 - 07:04 PM

NEW YORK--(BUSINESS WIRE)--Carson, creators of the complete technology service staffed residential buildings, and Mul-T-Lock, an ASSA ABLOY Group Brand, developer of the SMARTair electronic door lo... more »
Phase 3 Data on Filgotinib in Biologic-Experienced Rheumatoid Arthritis to Be Presented at 2018 ACR/ARHP Annual Meeting

10/20/2018 - 06:30 PM

CHICAGO--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced detailed results from the Phase 3 FINCH 2 clinical trial of filgotinib,... more »
New Tool Under Development May Help Arthritis Patients Better Assess Risks and Benefits of Treatment Choices, Study Shows

10/20/2018 - 05:30 PM

UPPER NYACK, N.Y.--(BUSINESS WIRE)--ArthritisPower® and CreakyJoints® data featured in one oral presentation and seven posters at 2018 ACR/ARHP Annual Meeting. more »
Takeda präsentiert Ergebnisse aus der Phase-3-Studie ALTA-1L, die die intrakranielle Wirksamkeit von ALUNBRIG® (Brigatinib) gegenüber Crizotinib in der Erstlinientherapie beim ALK-positiven...

10/20/2018 - 04:33 PM

CAMBRIDGE, Massachusetts (USA) und OSAKA (Japan)--(BUSINESS WIRE)--Takeda präsentiert Ergebnisse aus der Phase-3-Studie ALTA-1L, die die intrakranielle Wirksamkeit von ALUNBRIG® (Brigatinib) gegenü... more »
Statement from the Russian Direct Investment Fund Relating to the Khashoggi Case

10/20/2018 - 01:21 PM

MOSCOW--(BUSINESS WIRE)--Russian Direct Investment Fund welcomes the decisive actions taken by Saudi Arabia as a result of the official investigation of Jamal Khashoggi’s case to punish and prosecu... more »
Genentech’s Tecentriq in Combination With Abraxane Improves Outcomes as an Initial Treatment for People With PD-L1-Positive Metastatic Triple-Negative Breast Cancer

10/20/2018 - 10:30 AM

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced positive results from the Phase III IMpassion130 study of Tecentri... more »
Pfizer Presents Overall Survival Data From PALOMA-3 Trial of IBRANCE® (palbociclib) in Patients With HR+, HER2- Metastatic Breast Cancer

10/20/2018 - 10:30 AM

NEW YORK--(BUSINESS WIRE)--Pfizer Inc.(NYSE:PFE) today announced detailed overall survival (OS) data from the PALOMA-3 trial, which evaluated IBRANCE® (palbociclib) in combination with fulvestrant ... more »
Medical Society of the District of Columbia Honors Neal Barnard, M.D., F.A.C.C.

10/20/2018 - 10:29 AM

WASHINGTON--(BUSINESS WIRE)--The Medical Society of the District of Columbia (MSDC) will present Neal Barnard, M.D., F.A.C.C., its Distinguished Service Award at MSDC’s 201st Annual Meeting and Rec... more »
Infiniti Research Reveals Five Promising Trends Emerging in the Food Packaging Market

10/20/2018 - 09:31 AM

LONDON--(BUSINESS WIRE)--Trends emerging in the food packaging market. more »
Quantzig Reveals the Challenges Hindering the Adoption of Blockchain in Healthcare

10/20/2018 - 09:27 AM

LONDON--(BUSINESS WIRE)--The challenges hindering the adoption of blockchain in healthcare. more »
Quantzig Predicts the Future of Bitcoin - Proclaims It a Gamble

10/20/2018 - 09:19 AM

LONDON--(BUSINESS WIRE)--The future of bitcoin. more »
First Presentation of Early Data for Merck’s Investigational STING Agonist (MK-1454) in Patients with Advanced Solid Tumors or Lymphomas at ESMO 2018 Congress

10/20/2018 - 09:00 AM

KENILWORTH, N.J.--(BUSINESS WIRE)--First Presentation of Early Data for Merck’s Investigational STING Agonist (MK-1454) in Patients with Advanced Solid Tumors or Lymphomas at ESMO 2018 more »
Exelixis Announces Results from Two Analyses Evaluating Effect of PD-L1 Expression or Prior Treatment with Checkpoint Inhibitors on Efficacy of Cabozantinib in Patients with Advanced Renal Cell Carcinoma

10/20/2018 - 08:45 AM

ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today announced results from two analyses evaluating the effect of PD-L1 expression or prior treatment with immune checkpoint inhibito... more »

1 2 3 4 5 6 7 8 9 10 11 ... 1150